We conduct the studies on AG1 with third-party experts to validate our design and data, and mitigate bias. For the in vitro study, we used a pre-clinical research lab that offers best-in-class simulations of the human gastrointestinal tract and an extended team of scientists. For both the observational and clinical trial, we worked with third-party clinical research centers to mitigate bias.
We publish our research and results in peer-reviewed journals, which require a rigorous review and approval process by other experts within the scientific community. These are available on our site.